GLP-1 Muscle Loss — The Hidden Risk - The Race to Build a Better Drug

from GLP-1 Muscle Loss — The Hidden Risk · host Inception Point Ai

Host Ben Synth explores groundbreaking research on GLP-1 weight loss drugs and muscle preservation. He examines the BELIEVE study combining semaglutide with bimagrumab, which achieved 92.8% fat loss versus lean tissue loss, and discusses revolutionary continuous biosensor technology tracking muscle breakdown in real-time for patients on medications like Ozempic and Mounjaro.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Episode metadata supplied by the publisher feed · Published Apr 7, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

GLP-1 Muscle Loss — The Hidden Risk - The Race to Build a Better Drug

0:00 24:34

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of GLP-1 Muscle Loss — The Hidden Risk?

This episode is 24 minutes long.

When was this GLP-1 Muscle Loss — The Hidden Risk episode published?

This episode was published on April 7, 2026.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this GLP-1 Muscle Loss — The Hidden Risk episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!